Sickle cell disease in North London

Area of Science:

• Hematology
• Public Health
• Genetics

Background:

• Sickle cell disease (SCD) is a significant global health concern.
• Understanding regional variations in SCD complications is crucial for targeted healthcare strategies.
• The Haringey Sickle Cell Register provides a valuable dataset for analyzing SCD epidemiology in the UK.

Purpose of the Study:

• To analyze the 20-year experience of managing sickle cell disease in the London Borough of Haringey.
• To compare the incidence of SCD complications in the UK with data from Jamaica.
• To evaluate the effectiveness of managing pregnant SCD patients with regular blood transfusions.

Main Methods:

• Retrospective analysis of patient data from the Haringey Sickle Cell Register (1966-1986).
• Comparison of complication rates (painful crises, acute chest syndrome, splenomegaly, leg ulceration) with Jamaican data.
• Review of management protocols and outcomes for pregnant SCD patients.

Main Results:

• Haringey SCD patients (n=145) showed more frequent painful crises but less frequent acute chest syndrome compared to Jamaica.
• Lower incidence of splenomegaly and leg ulceration was observed in UK patients (Hb SS and Hb SC) versus Jamaica.
• Alloimmunization occurred in 21% of transfused patients; pregnant SCD patients managed with transfusion had no maternal or fetal mortality, though some infants were small for dates.
• No significant seasonal variation in hospital admissions for painful crises was identified.

Conclusions:

• Sickle cell disease management in the UK shows distinct epidemiological patterns compared to Jamaica, with generally fewer severe complications like leg ulcers.
• Regular blood transfusions are effective in managing pregnant SCD patients, ensuring positive maternal and fetal outcomes.
• Further research into the specific factors influencing these regional differences in SCD presentation and outcomes is warranted.